Backwards Walking Programme Following Hip and Knee Arthroplasty
NCT ID: NCT04247802
Last Updated: 2025-01-10
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2020-08-05
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Rehabilitation in Gait Recovery After Knee or Hip Arthroplasty
NCT04803578
Prediction of Outcomes Following Total Knee Replacement
NCT01370421
Does Rapid Mobilisation Improve Length of Stay and Outcomes Post THR
NCT02428829
An Exploration Into the Young Patients' (< 50 Years) Expectations Following Primary Total Hip Arthroplasty
NCT04660149
Study on the Functionality, Safety and Reliability of a Robotic Prosthesis for the Lower Limb At the Transfemoral Level
NCT06284005
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Backwards Walking (BW) programme
This group will undertake a routine course of one to one out-patient physiotherapy which will include a BW programme. The BW programme will be prescribed by a physiotherapist and the participant will carry it out, along with other prescribed exercises, in their own home. Each participant will initially be prescribed a 5 minute BW programme to be completed once a day. The length of the BW programme and intensity will be progressed or regressed as deemed appropriate by the treating clinician with the aim for patients to achieve at least 10 minutes of BW every day of the week.
Backwards Walking (BW) programme
A 12 week Backwards walking programme prescribed by a registered physiotherapist and completed as part of a home exercise programme.
Usual Care
This group will undertake a routine course of one to one out-patient physiotherapy over 12 weeks. To allow comparison between the two groups the control group will also have up to four review appointments where their home exercise programme can be progressed or regressed. The physiotherapy treatments will be not be restricted (apart from no BW programme) to allow for a pragmatic approach based on the treating clinician's clinical judgement, however their content will be recorded on treatment logs.
Usual Care
A 12 week physiotherapy exercise programme EXCLUDING backwards walking
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Backwards Walking (BW) programme
A 12 week Backwards walking programme prescribed by a registered physiotherapist and completed as part of a home exercise programme.
Usual Care
A 12 week physiotherapy exercise programme EXCLUDING backwards walking
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is willing and able to give informed consent for participation in the study.
* Participants who have received a primary unilateral hip or knee arthroplasty due to osteoarthritis.
Exclusion Criteria
* Post-operative complications such as infection, a deep vein thrombosis or pulmonary embolism, or failure of the wound to heal.
* Inability to undertake a backwards walking programme due to conditions such as severe cardiovascular or pulmonary disease (New York Heart Association III-IV).
* Severe dementia or communication difficulties that would prevent completion of study assessments.
* Any neurological condition.
* Further planned treatment on the same or contralateral hip or knee within the next 6 months.
* Registered as visually impaired.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oxford University Hospitals NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martha Batting
Role: PRINCIPAL_INVESTIGATOR
Oxford University Hospitals NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Horton General Hospital
Banbury, Oxfordshire, United Kingdom
Nuffield Orthopaedic Centre
Oxford, Oxfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
272567
Identifier Type: OTHER
Identifier Source: secondary_id
PID14748
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.